Research progress of extracellular vesicles as biomarkers in immunotherapy for non-small cell lung cancer
Lung cancer is one of the most severe forms of malignancy and a leading cause of cancer-related death worldwide, of which non-small cell lung cancer (NSCLC) is the most primary type observed in the clinic. NSCLC is mainly treated with surgery, radiotherapy, and chemotherapy. Additionally, targeted t...
| 出版年: | Frontiers in Immunology |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Frontiers Media S.A.
2023-04-01
|
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1114041/full |
